Skip to main content
SGRY
NASDAQ Industrial Applications And Services

Surgery Partners to Be Acquired by HealthSpan Partners for $23.50 Per Share in $5.7B Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
10
Price
$19.47
Mkt Cap
$2.062B
52W Low
$11.41
52W High
$23.44
52W Position info
71% above low
Off High info
17% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

SGRY sits 71% above its 52-week low of $11.41.

Summary

Surgery Partners has signed a definitive agreement to be acquired by HealthSpan Partners, an affiliate of Bon Secours Mercy Health, for $23.50 per share in cash, valuing the company at about $5.7 billion enterprise value. Bain Capital will roll over its roughly 39% stake and vote for the deal, which is expected to close in the first quarter of 2027.


Key Events · M&A and Partnerships · SGRY

  • Take-Private at $23.50 Per Share

    HealthSpan Partners will acquire Surgery Partners in an all-cash merger at $23.50 per share, an enterprise value of approximately $5.7 billion.

  • Bain Rolls Over 39% Stake

    Bain Capital affiliates holding 49,946,972 shares will contribute them to the buyer for equity rather than cash and have agreed to vote in favor under a Voting and Support Agreement.

  • $109M Break Fee and Outside Date

    The company would owe a $108,986,842 termination fee in specified circumstances; the outside date is July 23, 2027, extendable to October 23, 2027.

  • Closing Targeted for Q1 2027

    Completion requires a majority stockholder vote plus a majority of disinterested shares, HSR clearance and healthcare regulatory approvals; closing is expected in the first quarter of 2027.


Analysis · SGRY · Industrial Applications And Services

With the definitive merger agreement signed, Surgery Partners becomes a take-private target at a fixed $23.50 per share in cash, implying an enterprise value of roughly $5.7 billion. Until closing, that price is the stock's reference point, so shares should trade near it rather than on operating results. Approval risk is largely removed: Bain Capital, which owns about 39% of the shares, has locked in a rollover and a vote in favor. What remains is the stockholder vote, antitrust clearance and healthcare regulatory approvals, with a July 23, 2027 outside date and a $108,986,842 break fee if the company walks for a better offer.

At the time of this filing, SGRY was trading at $19.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $11.41 to $23.44. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SGRY - Latest Insights

SGRY
Oct 26, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $19.47
Real-time Price: $19.47 info
Change: $0 (0%) info
Market Cap: $2.062B info
SGRY
Oct 25, 2026, 2:20 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $15.80
Real-time Price: $19.47 info
Change: +$3.67 (+23%) info
Market Cap: $2.062B info
SGRY
Sep 17, 2026, 9:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.35
Real-time Price: $19.47 info
Change: +$6.12 (+46%) info
Market Cap: $2.062B info
SGRY
Aug 10, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $15.95
Real-time Price: $19.47 info
Change: +$3.52 (+22%) info
Market Cap: $2.062B info
SGRY
Jul 24, 2026, 9:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.70
Real-time Price: $19.47 info
Change: +$3.77 (+24%) info
Market Cap: $2.062B info